Skip to main content
. 2020 Feb 12;15(2):e0228615. doi: 10.1371/journal.pone.0228615

Table 1. Baseline demographics, duration of disease and therapy of patients.

UC
N = 49
Active UC
N = 19
Non-UC
N = 23
Age (years)
    Mean (SD) 38·5 (15·6) 36.13 36·7 (15·9)
    Range 24–74 19–71 21–59
Gender (% male) 46 42 42
Duration of UC (years)
    Mean (SD) 11·6 (9·53) 11.46 (10.97)
    Range 1–40 1–39
SCCAI
    Mean (SD) 3·04 (2·79) 6.42 (2.19)
    Range 0–13 5–13
Treatment (current)
    TNFα-blocker 20 6
    Glucocorticoids 13 8
    Mesalazine 26 9
    Immuno-suppressive 6 3
    No 10 3
Atopic Dermatitis 3